drugset / Trial / NCT02805166
PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to estimate the safety and efficacy of PEG-rhG-CSF in patients with lung cancer,head and neck cancer,colorectal cancer,and ovarian cancer receiving multi-cycle chemotherapy.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegfilgrastim | Protein / enzyme biologic | 100 ug/kg | Subcutaneous |